Tuesday, June 9, 2020

Lilly's Ambition to Extend its Legacy in Neurology

Big Pharma Eli Lilly & Co. (LLY) just announced yet another joint venture with a promising Biotech business: Evox Therapeutics, based in Oxford, England.  This time the focus is Neurology.

Eli Lilly currently does not have much of a neurological portfolio.  However, its history is rich in it.

Prozac was invented by Eli Lilly & Co. (LLY), and soon swept the world as the first highly effective drug for depression.

Zyprexa was extremely profitable until it went generic almost 10 years ago.  It took in sales of over 5 billion per year.

I buy and use the Eli Lilly drug that was known as Zyprexa along with Depakote that was sold by AbbVie Inc. (ABBV).  I've been injected with most of the drugs in the psychiatric arsenal.  And, Zyprexa and Depakote are the only ones I tolerate.

While a new drug would have to have a really good reputation to get me to try it, I would still love to see Eli Lilly & Co. (LLY) extend its proud tradition in neurological medicine.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

No comments:

Post a Comment